Does VISMODEGIB Cause Therapy cessation? 39 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 39 reports of Therapy cessation have been filed in association with VISMODEGIB (ERIVEDGE). This represents 0.5% of all adverse event reports for VISMODEGIB.
39
Reports of Therapy cessation with VISMODEGIB
0.5%
of all VISMODEGIB reports
0
Deaths
15
Hospitalizations
How Dangerous Is Therapy cessation From VISMODEGIB?
Of the 39 reports, 15 (38.5%) required hospitalization.
Is Therapy cessation Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for VISMODEGIB. However, 39 reports have been filed with the FAERS database.
What Other Side Effects Does VISMODEGIB Cause?
Muscle spasms (1,937)
Alopecia (1,330)
Ageusia (958)
Fatigue (899)
Dysgeusia (706)
Weight decreased (688)
Nausea (669)
Decreased appetite (662)
Death (657)
Diarrhoea (446)
What Other Drugs Cause Therapy cessation?
DALFAMPRIDINE (4,580)
ETANERCEPT (2,031)
ADALIMUMAB (1,712)
ABIRATERONE (1,602)
VOXELOTOR (1,038)
CLOZAPINE (885)
LOMITAPIDE (828)
CAPECITABINE (746)
TREPROSTINIL (743)
ISOTRETINOIN (633)
Which VISMODEGIB Alternatives Have Lower Therapy cessation Risk?
VISMODEGIB vs VITAMIN A
VISMODEGIB vs VITAMIN B
VISMODEGIB vs VITAMIN D NOS
VISMODEGIB vs VITAMINS
VISMODEGIB vs VOCLOSPORIN